Oct 24 (Reuters) - A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of researchers reported at a major European oncology ...

We were the first in Europe to develop chemotherapeutic agents. We discovered, and with The Royal Marsden developed, the chemotherapy drugs busulfan, chlorambucil, melphalan and carboplatin, which are ...

Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy solutions, experts say.

The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...

Cancer cells rapidly adapt to treatments, developing resistance that makes chemotherapy less effective. Researchers used an existing anti-inflammatory drug to disrupt cancer cells’ ability to adapt by ...

A new wave of cancer treatments is looking promising for the future of oncologic care. The ovarian cancer drug RC88, which is made by the Chinese biopharmaceutical company RemeGen, received FDA ...

Better care for cancer patients may be on the horizon. A new prescription medicine for treating cervical cancer has been showing positive results in clinical trials. In phase 3 global trials, TIVDAK ...

Drug shortages have reached an all-time high in the United States. During the first three months of 2024, there were 323 drugs in active shortage, according to data from the American Society of Health ...

Pfizer is launching the first clinical trials for its PD-1xVEGF drug, while Akeso detailed the first overall survival win for ...

Drug shortages have reached a record high in the first three months of 2024. In the first quarter of the year, 323 drugs were running low, surpassing the 2014 high of 320, according to data provided ...

A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of ...

The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...